LEDGF/p75 Overexpression Attenuates Oxidative Stress-Induced Necrosis and Upregulates the Oxidoreductase ERP57/PDIA3/GRP58 in Prostate Cancer

PloS One
Anamika BasuC A Casiano

Abstract

Prostate cancer (PCa) mortality is driven by highly aggressive tumors characterized by metastasis and resistance to therapy, and this aggressiveness is mediated by numerous factors, including activation of stress survival pathways in the pro-inflammatory tumor microenvironment. LEDGF/p75, also known as the DFS70 autoantigen, is a stress transcription co-activator implicated in cancer, HIV-AIDS, and autoimmunity. This protein is targeted by autoantibodies in certain subsets of patients with PCa and inflammatory conditions, as well as in some apparently healthy individuals. LEDGF/p75 is overexpressed in PCa and other cancers, and promotes resistance to chemotherapy-induced cell death via the transactivation of survival proteins. We report in this study that overexpression of LEDGF/p75 in PCa cells attenuates oxidative stress-induced necrosis but not staurosporine-induced apoptosis. This finding was consistent with the observation that while LEDGF/p75 was robustly cleaved in apoptotic cells into a p65 fragment that lacks stress survival activity, it remained relatively intact in necrotic cells. Overexpression of LEDGF/p75 in PCa cells led to the upregulation of transcript and protein levels of the thiol-oxidoreductase ERp57 (also ...Continue Reading

References

Apr 14, 1999·Cell Death and Differentiation·G P Amarante-MendesD R Green
Oct 12, 2000·Biochemical and Biophysical Research Communications·P SharmaT Shinohara
May 15, 2001·Biochemical and Biophysical Research Communications·D P SinghT Shinohara
Jun 8, 2002·Progress in Retinal and Eye Research·Toshimichi ShinoharaNigar Fatma
Jan 13, 2004·Cell Biochemistry and Biophysics·Lars Ellgaard, Eva-Maria Frickel
Nov 4, 2004·Experimental Biology and Medicine·Amy C LongJoshua A Bomser
Jun 30, 2005·Arthritis and Rheumatism·Fabio J PachecoCarlos A Casiano
Sep 12, 2006·Free Radical Biology & Medicine·Caterina GrilloFabio Altieri
Sep 19, 2006·Molecular and Cellular Biology·Heidi G SutherlandWendy A Bickmore
Mar 7, 2007·Molecular Cancer Therapeutics·Uma T ShankavaramJohn N Weinstein
Mar 27, 2007·Nature Reviews. Cancer·Angelo M De MarzoWilliam G Nelson
Oct 4, 2007·Proceedings of the National Academy of Sciences of the United States of America·Angela Kwok Fung LoS Diane Hayward
May 7, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Svetlana V KalinichenkoIgor V Korobko
Jul 5, 2008·Cancer Cell·Akihiko Yokoyama, Michael L Cleary
Aug 19, 2008·Molecular Cancer Research : MCR·Terry A Brown-BryanCarlos A Casiano
Feb 3, 2009·Cancer Letters·Lakshmipathi KhandrikaHari K Koul
Oct 13, 2009·Cancer Immunology, Immunotherapy : CII·Barbara SeligerArndt Hartmann
Jan 8, 2010·Molecular Cancer Therapeutics·Paul RammerMarja Jäättelä
Jan 19, 2010·The International Journal of Biochemistry & Cell Biology·Helen Coe, Marek Michalak
Mar 3, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Rik GijsbersZeger Debyser
May 21, 2010·Nucleic Acids Research·Jan De RijckRik Gijsbers
Jul 3, 2010·International Journal of Oncology·Doobyung ChayJae-Hoon Kim
Aug 13, 2011·Cellular & Molecular Biology Letters·Carlo TuranoSilvia Chichiarelli

❮ Previous
Next ❯

Citations

Jun 20, 2020·Future Medicinal Chemistry·Brian M LinharesTomasz Cierpicki
Feb 6, 2018·Current Opinion in Rheumatology·Dolores Pérez, Danielle Azoulay
Mar 30, 2018·Frontiers in Cell and Developmental Biology·Shirisha ChittiboyinaSophie A Lelièvre
Apr 30, 2017·Experimental & Molecular Medicine·Kwangbeom HyunJaehoon Kim
Nov 29, 2017·Molecular and Clinical Oncology·Thierry RoumeguèreFouad Aoun
Jul 12, 2019·Canadian Journal of Physiology and Pharmacology·Katsuya IuchiShigeo Ohta
Aug 31, 2019·Biochemical and Biophysical Research Communications·Wu-Tao WangChao-Hui Sun

❮ Previous
Next ❯

Methods Mentioned

BETA
Fluorescence
flow cytometry
PCR
Assay
Immunoprecipitation
ChIP

Software Mentioned

Primer3
Kinexus
SAS
Excel

Related Concepts

Related Feeds

AIDS Malignancies (ASM)

HIV infection increases the risk of non-communicable diseases common in the aged, including cardiovascular disease, neurocognitive decline, non-aids malignancies, osteoporosis, and frailty. Discover the latest research in AIDS malignancies.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

HIV/AIDS-Related Malignancies

HIV/AIDS infection increases the risk of non-communicable diseases common in the aged including HIV/AIDS-related malignancies. Discover the latest research in HIV/AIDS-related malignancies.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis